These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15348624)

  • 21. Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patch.
    Harrison LI; Riedel DJ; Chang SF; Jacobson JP; Sellers JA; Kanniainen CM; Crowley JK; Hinderling PH
    Ther Drug Monit; 1997 Feb; 19(1):37-42. PubMed ID: 9029744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systemic evaluation of drug in acrylic pressure sensitive adhesive patch in vitro and in vivo: The roles of intermolecular interaction and adhesive mobility variation in drug controlled release.
    Liu C; Quan P; Li S; Zhao Y; Fang L
    J Control Release; 2017 Apr; 252():83-94. PubMed ID: 28274741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women.
    Rohr UD; Volko CD; Schindler AE
    Horm Mol Biol Clin Investig; 2014 Jun; 18(3):123-36. PubMed ID: 25390008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD; Ehrly AM; Kuhl H
    Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Numerical study of a drug release profile in the transdermal drug delivery system.
    Zeng J; Tikare V; Jacob KI
    Langmuir; 2006 Jan; 22(3):1333-40. PubMed ID: 16430302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Predictive Model for the Stabilizer Concentration Estimation in Microreservoir Transdermal Drug Delivery Systems Using Lipophilic Pressure-Sensitive Adhesives as Matrix/Carrier.
    Chenevas-Paule C; Wolff HM; Ashton M; Schubert M; Dodou K
    J Pharm Sci; 2017 May; 106(5):1371-1383. PubMed ID: 28163134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural analysis of polymorphism and solvation in tranilast.
    Vogt FG; Cohen DE; Bowman JD; Spoors GP; Zuber GE; Trescher GA; Dell'orco PC; Katrincic LM; Debrosse CW; Curtis Haltiwanger R
    J Pharm Sci; 2005 Mar; 94(3):651-65. PubMed ID: 15666296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection and use of crystallization inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids.
    Lipp R
    J Pharm Pharmacol; 1998 Dec; 50(12):1343-9. PubMed ID: 10052847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixture design approach for early stage formulation development of a transdermal delivery system.
    Michaelis M; Leopold CS
    Drug Dev Ind Pharm; 2015; 41(9):1532-40. PubMed ID: 25308745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on Aspirin Crystals Generated by a Modified Vapor Diffusion Method.
    Mittal A; Malhotra D; Jain P; Kalia A; Shunmugaperumal T
    AAPS PharmSciTech; 2016 Aug; 17(4):988-94. PubMed ID: 26729528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a Drug-in-Adhesive Transdermal Patch for Risperidone: Effect of Drug-Additive Interactions on the Crystallization Inhibition and In Vitro/In Vivo Correlation Study.
    Weng W; Quan P; Liu C; Zhao H; Fang L
    J Pharm Sci; 2016 Oct; 105(10):3153-3161. PubMed ID: 27522527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-destructive analysis of tulobuterol crystal reservoir-type transdermal tapes using near infrared spectroscopy and imaging.
    Sakamoto T; Fujimaki Y; Takada Y; Aida K; Terahara T; Kawanishi T; Hiyama Y
    J Pharm Biomed Anal; 2013 Feb; 74():14-21. PubMed ID: 23245228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical mapping of tulobuterol in transdermal tapes using microscopic laser Raman spectroscopy.
    Sakamoto T; Matsubara T; Sasakura D; Takada Y; Fujimaki Y; Aida K; Miura T; Terahara T; Higo N; Kawanishi T; Hiyama Y
    Pharmazie; 2009 Mar; 64(3):166-71. PubMed ID: 19348338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barium hydrogen phosphate/gelatin composites versus gelatin-free barium hydrogen phosphate: synthesis and characterization of properties.
    Gashti MP; Burgener M; Stir M; Hulliger J
    J Colloid Interface Sci; 2014 Oct; 431():149-56. PubMed ID: 24996024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal application of steroid hormones for contraception.
    Sitruk-Ware R
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):247-51. PubMed ID: 7626463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solvent effects on physicochemical behavior of estradiols recrystallized for transdermal delivery.
    Park JS; Park YJ; Kang HW; Kim CK
    Arch Pharm Res; 2008 Jan; 31(1):111-6. PubMed ID: 18277616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch.
    Lake Y; Pinnock S
    Aust N Z J Obstet Gynaecol; 2000 Aug; 40(3):313-6. PubMed ID: 11065040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.